Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on July 11, 2005

Circulation. 2005
Published online before print July 11, 2005, doi: 10.1161/CIRCULATIONAHA.104.508333
A more recent version of this article appeared on July 19, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
112/3/400    most recent
CIRCULATIONAHA.104.508333v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, M.
Right arrow Articles by Hohlfeld, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, M.
Right arrow Articles by Hohlfeld, T.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Cardiomyopathy
Related Collections
Right arrow Contractile function
Right arrow Ischemic biology - basic studies
Right arrow Receptor pharmacology

Submitted on September 22, 2004
Revised on March 17, 2005
Accepted on March 30, 2005

Cardiospecific Overexpression of the Prostaglandin EP3 Receptor Attenuates Ischemia-Induced Myocardial Injury

Melanie Martin BSc, Jutta Meyer-Kirchrath PhD, Gernot Kaber BSc, Christoph Jacoby PhD, Ulrich Flögel PhD, Jürgen Schrader MD, Ulrich Rüther PhD, Karsten Schrör MD, and Thomas Hohlfeld MD*

From the Institut für Pharmakologie und Klinische Pharmakologie (M.M., J.M.-K., G.K., K.S., T.H.), Institut für Herz- und Kreislaufphysiologie (C.J., U.F., J.S.), and Institut für Entwicklungs- und Molekularbiologie (U.R.), Heinrich-Heine-Universität, Düsseldorf, Germany.

* To whom correspondence should be addressed. E-mail: hohlfeld{at}uni-duesseldorf.de.

Background--The generation of prostaglandin E2 (PGE2) is significantly increased in acute myocardial ischemia and reperfusion. PGE2, in addition to other prostaglandins, protects the reperfused ischemic myocardium. It has been hypothesized that this cardioprotection is mediated by E-type prostaglandin receptors of the Gi-coupled EP3 subtype.

Methods and Results--We tested this hypothesis by generating transgenic (tg) mice with cardiospecific overexpression of the EP3 receptor. According to ligand binding, a 40-fold overexpression of the EP3 receptor was achieved in membranes prepared from tg hearts compared with wild-type (wt) littermates. In isolated cardiomyocytes from tg mice, the forskolin-induced rise in cAMP was markedly attenuated, indicating coupling of the overexpressed EP3 receptor to inhibitory G proteins (Gi) with constitutive receptor activity. There was no evidence for EP3 receptor coupling to Gq-mediated protein kinase C signaling. Isolated hearts from tg and wt mice were subjected to 60 minutes of no-flow ischemia and 45 minutes of reperfusion. In tg hearts, ischemic contracture was markedly delayed compared with wt hearts, and the ischemia-induced increase in left ventricular end-diastolic pressure was reduced by 55%. Creatine kinase and lactate dehydrogenase release was significantly decreased by 85% and 73%, respectively, compared with wt hearts.

Conclusions--Constitutive prostaglandin EP3 receptor signaling exerts a protective effect on cardiomyocytes, which is probably Gi mediated and results in a remarkable attenuation of myocardial injury during ischemia and reperfusion. Cardioprotective actions of E-type prostaglandins may be mediated by this receptor subtype.


Key words: contractility • contracture • creatine kinase • ischemia • prostaglandins




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
J. Meyer-Kirchrath, M. Martin, C. Schooss, C. Jacoby, U. Flogel, A. Marzoll, J. W. Fischer, J. Schrader, K. Schror, and T. Hohlfeld
Overexpression of prostaglandin EP3 receptors activates calcineurin and promotes hypertrophy in the murine heart
Cardiovasc Res, February 1, 2009; 81(2): 310 - 318.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. A. Frias, S. Somers, C. Gerber-Wicht, L. H. Opie, S. Lecour, and U. Lang
The PGE2-Stat3 interaction in doxorubicin-induced myocardial apoptosis
Cardiovasc Res, October 1, 2008; 80(1): 69 - 77.
[Abstract] [Full Text] [PDF]